Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes

Lusine Yaghjyan, Ashwini K. Esnakula, Christopher G. Scott, Akemi T. Wijayabahu, Matthew R. Jensen, Celine M Vachon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: High mammographic breast density is a strong, well-established breast cancer risk factor. Whether stem cells may explain high breast cancer risk in dense breasts is unknown. We investigated the association between breast density and breast cancer risk by the status of stem cell markers CD44, CD24, and ALDH1A1 in the tumor. Methods: We included 223 women with primary invasive or in situ breast cancer and 399 age-matched controls from Mayo Clinic Mammography Study. Percent breast density (PD), absolute dense area (DA), and non-dense area (NDA) were assessed using computer-assisted thresholding technique. Immunohistochemical analysis of the markers was performed on tumor tissue microarrays according to a standard protocol. We used polytomous logistic regression to quantify the associations of breast density measures with breast cancer risk across marker-defined tumor subtypes. Results: Of the 223 cancers in the study, 182 were positive for CD44, 83 for CD24 and 52 for ALDH1A1. Associations of PD were not significantly different across t marker-defined subtypes (51% + vs. 11–25%: OR 2.83, 95% CI 1.49–5.37 for CD44+ vs. OR 1.87, 95% CI 0.47–7.51 for CD44−, p-heterogeneity = 0.66; OR 2.80, 95% CI 1.27–6.18 for CD24+ vs. OR 2.44, 95% CI 1.14–5.22 for CD24−, p-heterogeneity = 0.61; OR 3.04, 95% CI 1.14–8.10 for ALDH1A1+ vs. OR 2.57. 95% CI 1.30–5.08 for ALDH1A1−, p-heterogeneity = 0.94). Positive associations of DA and inverse associations of NDA with breast cancer risk were similar across marker-defined subtypes. Conclusions: We found no evidence of differential associations of breast density with breast cancer risk by the status of stem cell markers. Further studies in larger study populations are warranted to confirm these associations.

Original languageEnglish (US)
JournalCancer Causes and Control
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Breast
Stem Cells
Breast Neoplasms
Neoplasms
Mammography
Tumor Biomarkers
Breast Density
Logistic Models
Population

Keywords

  • ALDH1A1
  • Breast cancer risk
  • Breast stem cell markers
  • CD24
  • CD44
  • Mammographic breast density

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes. / Yaghjyan, Lusine; Esnakula, Ashwini K.; Scott, Christopher G.; Wijayabahu, Akemi T.; Jensen, Matthew R.; Vachon, Celine M.

In: Cancer Causes and Control, 01.01.2019.

Research output: Contribution to journalArticle

Yaghjyan, Lusine ; Esnakula, Ashwini K. ; Scott, Christopher G. ; Wijayabahu, Akemi T. ; Jensen, Matthew R. ; Vachon, Celine M. / Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes. In: Cancer Causes and Control. 2019.
@article{26c4b5826f5d4ba48a18bc2f3f31e1b1,
title = "Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes",
abstract = "Purpose: High mammographic breast density is a strong, well-established breast cancer risk factor. Whether stem cells may explain high breast cancer risk in dense breasts is unknown. We investigated the association between breast density and breast cancer risk by the status of stem cell markers CD44, CD24, and ALDH1A1 in the tumor. Methods: We included 223 women with primary invasive or in situ breast cancer and 399 age-matched controls from Mayo Clinic Mammography Study. Percent breast density (PD), absolute dense area (DA), and non-dense area (NDA) were assessed using computer-assisted thresholding technique. Immunohistochemical analysis of the markers was performed on tumor tissue microarrays according to a standard protocol. We used polytomous logistic regression to quantify the associations of breast density measures with breast cancer risk across marker-defined tumor subtypes. Results: Of the 223 cancers in the study, 182 were positive for CD44, 83 for CD24 and 52 for ALDH1A1. Associations of PD were not significantly different across t marker-defined subtypes (51{\%} + vs. 11–25{\%}: OR 2.83, 95{\%} CI 1.49–5.37 for CD44+ vs. OR 1.87, 95{\%} CI 0.47–7.51 for CD44−, p-heterogeneity = 0.66; OR 2.80, 95{\%} CI 1.27–6.18 for CD24+ vs. OR 2.44, 95{\%} CI 1.14–5.22 for CD24−, p-heterogeneity = 0.61; OR 3.04, 95{\%} CI 1.14–8.10 for ALDH1A1+ vs. OR 2.57. 95{\%} CI 1.30–5.08 for ALDH1A1−, p-heterogeneity = 0.94). Positive associations of DA and inverse associations of NDA with breast cancer risk were similar across marker-defined subtypes. Conclusions: We found no evidence of differential associations of breast density with breast cancer risk by the status of stem cell markers. Further studies in larger study populations are warranted to confirm these associations.",
keywords = "ALDH1A1, Breast cancer risk, Breast stem cell markers, CD24, CD44, Mammographic breast density",
author = "Lusine Yaghjyan and Esnakula, {Ashwini K.} and Scott, {Christopher G.} and Wijayabahu, {Akemi T.} and Jensen, {Matthew R.} and Vachon, {Celine M}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10552-019-01207-w",
language = "English (US)",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",

}

TY - JOUR

T1 - Associations of mammographic breast density with breast stem cell marker-defined breast cancer subtypes

AU - Yaghjyan, Lusine

AU - Esnakula, Ashwini K.

AU - Scott, Christopher G.

AU - Wijayabahu, Akemi T.

AU - Jensen, Matthew R.

AU - Vachon, Celine M

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: High mammographic breast density is a strong, well-established breast cancer risk factor. Whether stem cells may explain high breast cancer risk in dense breasts is unknown. We investigated the association between breast density and breast cancer risk by the status of stem cell markers CD44, CD24, and ALDH1A1 in the tumor. Methods: We included 223 women with primary invasive or in situ breast cancer and 399 age-matched controls from Mayo Clinic Mammography Study. Percent breast density (PD), absolute dense area (DA), and non-dense area (NDA) were assessed using computer-assisted thresholding technique. Immunohistochemical analysis of the markers was performed on tumor tissue microarrays according to a standard protocol. We used polytomous logistic regression to quantify the associations of breast density measures with breast cancer risk across marker-defined tumor subtypes. Results: Of the 223 cancers in the study, 182 were positive for CD44, 83 for CD24 and 52 for ALDH1A1. Associations of PD were not significantly different across t marker-defined subtypes (51% + vs. 11–25%: OR 2.83, 95% CI 1.49–5.37 for CD44+ vs. OR 1.87, 95% CI 0.47–7.51 for CD44−, p-heterogeneity = 0.66; OR 2.80, 95% CI 1.27–6.18 for CD24+ vs. OR 2.44, 95% CI 1.14–5.22 for CD24−, p-heterogeneity = 0.61; OR 3.04, 95% CI 1.14–8.10 for ALDH1A1+ vs. OR 2.57. 95% CI 1.30–5.08 for ALDH1A1−, p-heterogeneity = 0.94). Positive associations of DA and inverse associations of NDA with breast cancer risk were similar across marker-defined subtypes. Conclusions: We found no evidence of differential associations of breast density with breast cancer risk by the status of stem cell markers. Further studies in larger study populations are warranted to confirm these associations.

AB - Purpose: High mammographic breast density is a strong, well-established breast cancer risk factor. Whether stem cells may explain high breast cancer risk in dense breasts is unknown. We investigated the association between breast density and breast cancer risk by the status of stem cell markers CD44, CD24, and ALDH1A1 in the tumor. Methods: We included 223 women with primary invasive or in situ breast cancer and 399 age-matched controls from Mayo Clinic Mammography Study. Percent breast density (PD), absolute dense area (DA), and non-dense area (NDA) were assessed using computer-assisted thresholding technique. Immunohistochemical analysis of the markers was performed on tumor tissue microarrays according to a standard protocol. We used polytomous logistic regression to quantify the associations of breast density measures with breast cancer risk across marker-defined tumor subtypes. Results: Of the 223 cancers in the study, 182 were positive for CD44, 83 for CD24 and 52 for ALDH1A1. Associations of PD were not significantly different across t marker-defined subtypes (51% + vs. 11–25%: OR 2.83, 95% CI 1.49–5.37 for CD44+ vs. OR 1.87, 95% CI 0.47–7.51 for CD44−, p-heterogeneity = 0.66; OR 2.80, 95% CI 1.27–6.18 for CD24+ vs. OR 2.44, 95% CI 1.14–5.22 for CD24−, p-heterogeneity = 0.61; OR 3.04, 95% CI 1.14–8.10 for ALDH1A1+ vs. OR 2.57. 95% CI 1.30–5.08 for ALDH1A1−, p-heterogeneity = 0.94). Positive associations of DA and inverse associations of NDA with breast cancer risk were similar across marker-defined subtypes. Conclusions: We found no evidence of differential associations of breast density with breast cancer risk by the status of stem cell markers. Further studies in larger study populations are warranted to confirm these associations.

KW - ALDH1A1

KW - Breast cancer risk

KW - Breast stem cell markers

KW - CD24

KW - CD44

KW - Mammographic breast density

UR - http://www.scopus.com/inward/record.url?scp=85069825721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069825721&partnerID=8YFLogxK

U2 - 10.1007/s10552-019-01207-w

DO - 10.1007/s10552-019-01207-w

M3 - Article

C2 - 31352658

AN - SCOPUS:85069825721

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

ER -